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ABSTRACT

The Gut Microbiome: Is Fecal Matter Microbial
Composition a Proxy for Intestinal Microbial
Composition in Studies of the
Microbiome?

by
Enrique Reyes
As many health phenomena seem to be affected directly and indirectly by the
microbiome, gut microbiome research has increased in the last decade. Issues such as allergies,
cancer, obesity, and other health complications have been shown to be influenced by the
microbiome. Most of gut microbiome research is done by collecting and sequencing the DNA of
the microbiome of the fecal matter from model organisms or human subjects. Studies that use
this method of sample collection and analysis assume that fecal matter microbiomes are similar
to intestinal microbiomes, and that it can be used as a proxy. At present, no published studies
exist which directly compare stool microbial composition and intestinal microbial composition.
Bacterial composition was found to be different at all levels of taxonomy between stool and the
different portions of the intestines tested. Uni-variate analysis shows significance between the
two main phyla Firmicutes and Bacteroidetes, as well as main genera like Odoribacter,
Porphyromonas and Alistipes. Relevant species Desulfovibrio desulfuricans and Odoribacter
splanchicus were also found to be significantly different in relative abundance between stool and
some parts of the intestines. Alpha-diversity was not significantly different between all parts of
the intestine and stool. Beta-diversity was significantly different between the ileum and stool,
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with stool having slightly higher diversity. Looking at the bacterial composition of both
environments and the relative abundances of the dominant taxa, one can see that that there are
key differences between the intestines and stool. The microbial composition at all levels of
taxonomy was found to be different, therefore, research that targets the gut microbiome should
look closely at the specific taxa being observed. Phyla like Firmicutes and Bacteroidetes were
found to have different abundance within the portions of the intestine and stool, suggesting that
phyla level analysis should be performed by observing each community separately.
Interestingly, diversity analysis was not found to be significant, suggesting the composition is
different, but the number of different taxa is similar across the intestinal tract and stool.
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CHAPTER I
LITERATURE REVIEW
The gut microbiome is currently a very popular field of study. Fifteen years ago, a
keyword search using the term “microbiome” on a journal’s search would have resulted in a very
limited number of papers. A more recent Google Scholar search using the term “microbiome
yielded over 200,000 papers. If the term “gut” is added to the search, 31,100 articles are found.
Microbiome scientists have found a field of research that may have an influence in all aspects of
biology and human health. Recent studies have shown connections between the composition of
the gut microbiome and: the immune system, mental health and brain chemistry, and obesity (1).
So far, gut microbiome researchers have only scratched the surface of some of these phenomena,
allowing for further research to assess the biological implications of the connections made,
adequacy of methodology and medical significance.

Gut Microbial Composition
The intestinal microbiome is a highly diverse system that is mostly composed of
commensal organisms. Biodiversity is defined as: “the variety and variability of biological
organisms”, Therefore, by these parameters, the microbiome is a highly diverse environment.
The gut microbial content varies between portions of the intestinal tract, but generally is made of
~103 - 1014 microbes per gram of content. The cumulative genomic material of the gut
microbiome contains 100 times more genes than our own genome (1). Human gut microflora is
dominated by member of two main phyla, the Firmicutes and Bacteroidetes, which form roughly
90% of the gut microbiome. Some of the more prevalent genera are Clostridium,

1

Bifidobacterium, Lactobacillus and Ruminococcus (2). Although the microbiome composition
varies during early development, in humans, it stabilizes around the age of three (3, 4).

Human Gut Microbial Composition
The area termed “the gut” for humans is shown in Figure 1. The stomach is inhabited
predominantly by organisms belonging to the genera Lactobacillus and Streptococcus. Bacterial
biodiversity is very low in this portion of the intestinal tract due to the highly acidic environment
of pH 1-2. Bacterial biodiversity in the duodenum and jejunum is higher due to the less acidic
environment of 5.7-6.4 pH. Organisms belonging to the genera Lactobacillus, Escherichia and
Enterococcus dominate this section of the intestinal tract. The ileum is a highly diverse
environment with many organisms belonging to the genera Enterobacter, Enterococcus,
Bacteroidetes, Clostridium and Lactobacillus. The ileum is a neutral environment with a pH
range of 7.3-7.7. In humans, the cecum and colon have similar community structure and
diversity. The cecum is the portion of the gut that connects the small intestine and the large
intestine. The colon is the portion closest to the rectum in the large intestine. These two sections
have neutral environments, and the highest number of species in the intestinal tract. Organisms
belonging to the genera: Bacteroidetes, Eubacterium, Bifidobacterium, Ruminococcus,
Propionobacterium, and others are found in these two sections of the intestinal tract (4; 5).
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Figure 1. Human Gastro-intestinal Tract microbial composition (4).

Mouse Gut Microbial Composition
Mice are the animal model most commonly used to study gut microbial composition and
the effects that changes in diet and exercise have on the gut microbiome. The gastro-intestinal
anatomy of the mouse is a similarly complex version of the human intestinal tract, with very
comparable structures (Figure 2). The human and mouse stomach are very similar to each other
and the human gut microbiome and the mouse gut microbiome are both dominated by the same
phyla, Firmicutes and Bacteroidetes. When looking deeper into the species taxonomic level, one
can observe differences between the human and mouse microbiomes. According to Ley and
colleagues 85% of microorganisms found in the mouse gut microbiome are not found in the
human gut microbiome (6). Another study took the task of assessing these finding by using
metagenomics techniques in already existing datasets of human fecal matter and mice cecal
samples. The researchers recognized that having only fecal matter data for humans (as opposed
to intestinal data) is a limiting feature of their study, but they found similar results to other
3

researchers in the field. The mouse microbiome and the human microbiome share a large number
of microorganisms with roughly 79 genera shared by both organisms (7).

Figure 2. Mouse intestinal tract vs. human intestinal tract (7).

Mouse intestinal microbial communities are composed of species belonging to the genera
Lactobacillus, Alistipes, Roseburia, Bifidobacterium, Clostridium, and others. This composition
is very similar to that of humans, but the content, as in abundance, seems to be different. The
relative abundances of these genera differ greatly between mouse and human, but, interestingly,
the species richness is similar (Figure 3). Although some differences are observed in abundances
of certain taxa, the mouse microbiome is still considered a good model to study microbial
communities and the effects of changes to the environment (8). Germ-free mice, for example, are
a great way to study the effect of certain microbial communities in the environment. These mice
have been bred in completely aseptic conditions; therefore, they do not have any microbiomes.
4

This allows the researcher to create a gut microbiome specific to individual mice under study.
Phenomena like obesity, dieting and probiotics have been studied using germ-free mice (8).

Figure 3. Relative abundances of certain intestinal genera are different between humans and mice, but
species richness is very similar (8).

Methodology for Microbial Community Identification and Comparison
Sample source
Recent gut microbiome research uses fecal matter as a source of the gut microbiome,
rather than samples taken directly from the intestine, primarily due to the relative ease of
collection. In a Google Scholar search for “gut microbiome”, the first twenty-two references that
appeared used feces rather than intestinal samples (Table 1). Interestingly, research that
specifically compares the composition of fecal microbiota to that obtained from intestinal
samples appears to be lacking.
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Table 1 Comparison between usage of stool samples as a proxy for gut microbial composition, usage of
intestinal samples, and the usage of both sample types.

Used feces as a proxy for
intestine microbial
composition
Turnbaugh et al.., 2009
Kalliomaki et al.., 2008
Mai et al.., 2011
Gill et al.., 2006
Ley et al.., 2006
Qin et al.., 2010
De Fillipo et al.., 2010
Ley et al.., 2005
Jumpertz et al.., 2011
Routy et al., 2018
Gopulakrishnan et al., 2018
Halfuorson et al., 2017
Xia et al., 2017
Wu et al., 2017
InSerra et al., 2019
Jin et al., 2019

Used intestinal samples

Used both fecal and
intestinal samples

Lagkouvardos et al.., 2016

Eckburg et al.., 2005
Kleessen et al.., 2001

Markle, et al.., 2013
Turbaugh et al.., 2006
Ravussin et al.., 2012

Nucleic-acid Based Techniques
The gut microbiome is a very challenging system to research and observe. Early
techniques used to identify species were culture based and employed biochemical testing. These
types of testing are beneficial to observe microorganism in pure cultures, but have proved
limiting for capturing the extent of species richness. Because more than 80% of our gut
microbiome is of anaerobic nature and fastidious in growth requirements, only about 1% of the
microbes in our gut have been cultivated in the laboratory setting with traditional culture-based
methods (9). Microbiome research that targets identification, characterization, and multiple
community comparisons have moved to use molecular-based techniques that use genetic data to

6

assess counts and abundance of each species. Nucleic acid-based techniques have been very
useful to identify organisms to the species and sub-species level, and have provided a new
avenue of research with the different possible questions they can answer. Some of these
techniques use bacterial ribosomal RNA and/or DNA, and others use the collective DNA
extracted from a particular environment (10) (Figure 4).

Figure 4. Diagram of microbiome characterization techniques (42).

16S rRNA amplicon sequencing
One technique that has been widely used in the field of gut microbiome research is 16S
rRNA amplicon sequencing. This technique uses rRNA sequences to provide a taxonomic profile
for microorganisms present in the environment. It is called rDNA amplicon sequencing because
it uses ribosomal RNA genes as a basis for taxonomic assignment. The ribosome is a structure
that serves as a protein generator (Figure 5). It uses amino acids and mRNA to yield a
polypeptide chain that eventually gets folded into a protein. The ribosome consists of several
sub-units, which in turn are categorized using a non-SI unit called Svedberg. The “S”, or
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Svedberg coefficient, is a non-SI unit that serves as a measure of how big and at what rate a
particle moves in an environment subjected to high G-force, such as those incurred in a
centrifuge. This unit is based on time, but it is not translated as seconds or minutes, but as a rate
of how fast can a molecule move, which correlates to how big it might be as well, therefore the
values assigned to each sub-unit are not additive, but only descriptive (11).

Figure 5. 3D structure of a bacterial ribosome. Green=small sub-unit, Blue=large sub-unit (43).

Prokaryotes (Bacteria and Archaea) have free-floating 70S ribosomes in their cytoplasm.
This ribosome is divided into a 30S (small) and a 50S (large) sub-unit, which are each divided
each into more sub-units. The 50S sub-unit is divided in two RNA molecules named 23S and 5S.
The 30S product contains the sub-unit that is most commonly used in prokaryotic taxonomy, the
16S subunit. Since it is the most conserved sequence and the easiest to track with PCR
(Polymerase Chain Reaction), the 16S rRNA gene is the preferred sequence for multiple
molecular-based techniques used to identify microorganisms in an environment. Figure 6 shows
the process of 16S rRNA amplicon generation. All prokaryotes have portions of the 16S
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sequence that is conserved, and multiple variable regions which can be used to differentiate
between phyla, genera and species. Some conserved regions are unique to prokaryotes and can
therefore be used as sites for primers to bind to amplify prokaryotic DNA. PCR amplification of
the variable regions tells the researcher the necessary information to assign taxonomic
designations by cross-referencing sample data with a public database that contains many known
sequences of bacterial 16S rDNA to pin-point the exact taxonomic designation for all the
sequences in the amplified sample (10). 16S rRNA amplicon sequencing has proven better, than
other nucleic-acid based techniques, for testing large samples, but it also has lower resolution
than other techniques. Other advantages of this technique are: it is able to exclude all nonbacterial organisms, ease of access, it can yield accurate taxonomic designations and is less labor
intensive (12).

Figure 6. 16S rRNA amplicon production process (42).

Metagenomics
A more sensitive technique that is also highly used in microbiome research is
metagenomics. Rather than amplifying and sequencing a single gene, metagenomics involves
9

extracting and sequencing all the DNA in a sample. This allows the researcher to find important
genes (virulence or certain metabolic genes, for example) and observe whether they are present
in the environment or not, providing information about metabolic pathways that can be
performed by that certain organism (14). Metagenomics not only allows for assignment of
taxonomic designations, but also reveals the whole gene repertoire of the system (13).
Techniques like “shotgun sequencing” and metagenome analysis can provide higher resolution,
allowing the researcher to assign designations as specific as sub-species and strain. These
techniques have proven useful for creating a genetic profile of the microbial environment, often
identifying specific genes that produce virulence factors or important enzymes more often than
other molecular-based technologies (13).

Metatranscriptomics
Metatranscriptomics is a group of techniques that study the transcriptome of a microbial
community. The transcriptome is the collective sum of messenger RNA and other RNA
products’ sequence information. The focus of these techniques is the isolation and sequencing of
RNA fragments to assess expression levels to infer metabolic activity and population viability.
(15; 16; 17). This technique can be challenging in environments that include both prokaryotic
and eukaryotic RNA. Prokaryote RNA does not have a poly-A tail, therefore selection during
cDNA synthesis is not possible as it is with eukaryotes. Probes targeting certain sequences of
RNA that are bound to magnetic beads to exclude the unwanted eukaryotic and ribosomal RNA
is a highly used method. RNA is then reverse-transcribed to cDNA and sequenced to determine
which genes were being expressed (15; 16; 17; 18).
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Metabolomics
Metabolomics is the branch of genomics that studies the metabolome. The metabolome is
the metabolic profile of microbial community in a particular an environment- it measures
metabolites such as sugars, proteins, and lipids. Metabolomics is currently used to identify
markers that could lead us to the development of diagnostic techniques for multiple diseases,
observe biochemical stresses, identify microbial metabolic products, and characterization of
disease-related metabolites (19; 20; 21; 22). Techniques like liquid and gas chromatography (LC,
GC), mass spectrometry (MS) and nuclear magnetic resonance (NMR) allow for the researcher
to develop a chemical profile of the system that can show what type of biochemical pathways are
occurring in the environment. These techniques are better employed in research geared towards
understanding the effect of metabolites on health and disease (23; 24; 25). Bacteria are
responsible for the breakdown and production of some of these metabolites that can be studied
through metabolomics. Metabolites like short-chain fatty acids (SCFAs), vitamins, other acids,
bile salts, amino acids and other biomolecules can be produced or transformed by bacteria
(Figure 7). Metabolomics can be used to create a metabolic profile that includes which
organisms are producing which of these metabolites (23)
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Figure 7. Gut microbial metabolites and signaling molecules (23).

Analysis of 16S rDNA data
Microbial community comparison bioinformatics uses 16S rDNA raw data to assign
taxonomic designations and to calculate the genomic relatedness of two or more communities.
The data is often extensive and complex. When studying the gut microbiome, each 16S RNA
gene amplicon is referred to as an operational taxonomic unit (OTU). Each OTU represents a
species of prokaryote. A single gut sample may have over 1000 species, where each species is
represented by a population ranging from 10 to several million members. It would take a great
amount of time to sort, group, analyze and plot these data. Therefore, multiple software
platforms have been developed to accelerate the process and to create informative figures that
accurately represent the composition of the microbiome. Software like mcaGUI, PICRUSt and
UniFrac, which use the R programing language, are some of the most widely used programs in
12

microbiome research. Other programs like Qiime and Mothur are also effective, but are Pythonbased and require a higher skill level in coding and bioinformatics. All of these programs are
ultimately used for 4 general categories of tasks. These categories are: (i) taxonomic assignation
of individual OTUs, (ii) functional profiling, or assigning genes to metabolic pathways that can
show the researcher the overall functional profile of the microbiome, (iii) community
comparison, which identifies differences and similarities between the OTU make-up of two or
more microbial communities, and (iv) meta-analysis, or the use of previously collected data to
draw conclusions about certain phenomena or environments (26).

mcaGUI
This open-source program uses the R language and environments to provide multiple
statistical tools and packages that can be used for microbial community comparison. It allows the
researcher to create OTU tables with the abundances and counts of organisms obtained from the
16S rDNA raw data. Other analysis can then be performed. Principal component analysis (PCA),
richness and diversity estimates, and multiple-community comparisons are the most popular
analyses performed (27).

UniFrac
UniFrac is a community comparison measurement that takes into account the genetic
relatedness of multiple communities. To assess the genetic distance between two communities it
uses phylogenetic trees that are individually formed for each sample (28). A phylogenetic tree is
a model used to display the genetic composition and history of an environment. This tree has
13

branches and nodes, which represent genetic distance and taxa or common ancestors
respectively. Branches that are closer together correspond to closely related
microorganisms/communities. Branches that are further apart correspond to less related
organisms and communities (29). UniFrac uses this model and by quantifying the phylogenetic
distance between different sets of taxa in terms of length of the branch, it can provide a
coefficient from 0-1 that corresponds to the level of relatedness between two or more
communities. Microbial communities can also be clustered in a plot, visually showing
similarities or differences between them (28). By using this measure one can observe that if
relative abundances of each OTU are not taken into account, then all organisms have the same
weight, yielding a UniFrac value that is only based on OTU richness. To reduce the impact that
presence has over abundance, a weighted UniFrac can be used. This measure allows the
researcher to observe similarities of communities by relative abundances and not just by
presence, diminishing the effect of low abundant present organisms. The un-weighted version
just looks at the presence of organisms giving equal statistical power to all OTUs even if they are
in low abundance in the environment (28;30).

MicrobiomeAnalyst
MicrobiomeAnalyst is a recently-developed web-based software that contains four
modules of work, which are the following: Maker Data Profiling, Shotgun Data Profilin,
Projection with Public Data and Taxon Set Enrichment Analysis. Maker Data Profiling is a
module that takes 16S rRNA sequence data and uses it to calculate measures like α−diversity
and β−diversity using a variety of statistical methods (Shannon, Chao-1, ACE, etc) (26). These
measurements are important because they measure the level of species richness and evenness in
14

an environment, and having high biodiversity is a marker of community health. α−diversity is
the richness and evenness of the organisms within a single community and β−diversity is the
richness and evenness between communities. Shannon’s index is a measurement of how diverse
a community is, while taking into account the total amount of organisms and total amount of
each organism. This index yields a value from 0-1. The closer to 1 it gets the more diverse the
environment is. SDP is a module meant to analyze and organize metagenomics and metatranscriptomics data. PPD allows for the researcher to compare the data obtained with already
published and analyzed data. Finally, TSEA is a module designed to assess the biological
implications or effects of a certain list of OTUs in the environment. For the purpose of this
project, MDP will be used, since it is the most appropriate module for the questions asked (26).
Figure 8 represents a flowchart that shows all possible analytic capabilities of
MicrobiomeAnalyst, depending on format input.

Figure 8. Microbiome Analyst flowchart representing all types of analysis depending on file input and
data type (26).
15

Gut Microbiome in Health and Disease
Multiple health related connections have been made between the gut microbiome and
various diseases and conditions. Microbiome researchers have connected diseases and disorders
like obesity, atopic diseases, allergies, stress, and others with the microbial composition of the
gut (31). Most of these studies have one aspect in common: the source of the samples used to
assess the composition of the gut. Evidence supporting connections between conditions and
diseases is based on the premise that stool microbial composition is a proxy for intestinal
microbial composition; therefore, only fecal matter is used for microbiome samples. Even though
no studies have demonstrated that fecal microbiomes are representative of the gut microbiome,
many studies have relied on fecal microbiome biome data for their experiments. Table 2
summarizes the relevant findings from select studies that have used mouse and human data from
both fecal and cecal microbiomes.

Knowledge gleaned from analysis of fecal samples
In an experiment aimed to investigate if gut microbial composition can precede obesity,
the researchers found that the presence of the genus Bifidobacterium was significantly decreased
in overweight children. Bifidobacterium species are responsible for controlling the populations of
other microbes during infancy. This suggested to the researchers that there is a link between
Bifidobacterium and obesity (32). Phyla like Firmicutes and Bacteroidetes have also been
16

connected to obesity. Obese individuals show an increase in the phylum Firmicutes compared to
Bacteroidetes, and lean individuals have a balanced proportion (33).
Germ-Free (GF) mice are a great model for assessment of the implications of certain
shifts in microbiome (dysbiosis) or the consequences of growth in a completely sterile
environment for gut microbial composition and organismal health. Some immunological diseases
and allergies have been correlated to microbial composition irregularities, or mal-developed
microbiome (34). Germ-Free mice show mal-developed gut associated lymphoid tissue, lower
counts of multiple leukocytes, poorly developed germinal centers, and low immunoglobulin
levels, suggesting that not having a microbiome causes an overall detriment to the development
of the immune system. (34). Certain microorganisms have been observed to aid in some of these
processes and in immunomodulation as well. Organisms like Lactobacilli and Escherichia have
been observed to induce T cell differentiation to a T helper lymphocyte 2 or T regulatory
responses. This led researchers to conclude that these organisms promote a tolerogenic
environment in the gastrointestinal tract (35). This, in turn, led microbiome researchers to
connect allergies and atopic diseases to gut microbial composition and microbiome development.
Disorders and conditions like stress, anxiety and depression, Autism Spectrum Disorder,
Parkinson ’s disease (Pd) and others have also been connected to dysbiosis and abnormalities in
the gut microbiome (36). In an experiment aimed at understanding the relationship between the
microbiome and stress, anxiety and depression, researchers found that GF mice have higher
corticosterone when challenged with restraint to promote stress, than Specific Pathogen Free
(SPF) mice. GF mice also exhibited reduced neurotrophic factor expression, which is a sign of
potential neuronal mal-development. All of these issues were reversed by reconstitution of
certain organisms such as Bifobacterium infantis (37). Other disorders and neurological diseases
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also share connections with the gut microbiome. For example, Pd was found to have a microbial
aspect to the underlying cause of the disease. Sampson and colleagues (38) investigated the
relationship between the gut microbiome and Pd’s pathophysiology. They found that GF mice
colonized with Pd microbiota display Pd symptoms and behavior as well as reduces microglia
activation. Microglia size and branching was reduced in Pd mice. The same was observed when
GF mice were given Pd microbiota. Mice that had Pd symptoms and Human Pd patient samples
had a higher UniFrac value than to the other sample groups. This indicates that Pd mice have
very similar microbiomes to human Pd patients, alluding to a microbial profile that can be
correlated to Pd (38).

Cecal Sample Collection
Another common sample collection method in the study of the effects of the gut
microbiome on human health using mice as a model organism is to take tissue sections from the
cecum. A few studies have used samples gained from tissue excision from the cecum or other
portions of the gut and extract DNA from that to assess the microbial composition of the
intestines (39;40;41). The research performed using this method of sample collection is scarce
and uses mouse models. From all the research done for this project only 3 relevant articles were
found to use only cecum sample collection (39;40;41).
An experiment focused on understanding the microbial composition of obese mice and
comparing it to control mice found that diet induced obese mice had higher bacterial diversity
that control mice. Also, when these mice were put under a regime to reduce weight, microbiome
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diversity increased greatly. The phylum Firmicutes was observed to decrease in this weight
reduction process, suggesting that the levels of these organisms are related to the obese
phenotype. The phylum Bacteroidetes was observed to decrease in obese mice and to
significantly increase during the weight reduction process, which suggests that there is a relation
between this phylum and the lean phenotype. All of this evidence showed the researchers that the
ratio of these two phyla might be correlated to the degree of obesity (39).
Results from another experiment changed the focus of study from obese phenotype to
energy harvest and determined how well the microbiome from an obese animal is able to harvest
nutrients and break down foods (40). The researchers found that samples from obese mice where
observed to have higher amounts of sequences that code for enzymes responsible for breaking
down indigestible elements. Also, GF mice gavaged with the microbiota of obese mice showed a
significant increase in fat percentage compared to that of mice gavaged with lean microbiota or
control microbiota (40). This evidence suggests that there is a strong bi-directional relationship
between metabolic processes of the body and the gut microbiome. This has been observed with
other systems as well, for example the immune system and the central nervous system (41;38).
Atopic diseases and autoimmune diseases like diabetes have also been correlated to gut
microbial composition. In an experiment geared towards understanding sex-biased microbial
composition and the potential of a hormonal induced microbial composition profile found that
female mice have a different microbiome than male mice (41). It also suggested, that this can be
a reason as to why women are more prone to diabetes. Using non-obese diabetic mice, the
researchers assessed the relatedness and the implications of having male and female
microbiomes in terms of glucose tolerance and insulin production. They concluded that females
gavaged with male microbiome increased glucose tolerance and decreased the degree of
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diabetes. This suggests that there is a sex-biased microbial composition that may confer
protection or prevention to diabetes. This is still being researched, therefore there are no known
mechanisms that underlie this process, but it is hypothesized that testosterone levels might be a
factor (41).

Table 2. Relevant finding from select studies that have used fecal and cecal data.

Microbiome Sample Source
Feces
Feces
Feces
Feces/Intestinal cell
imaging
Feces

Cecum
Cecum

Cecum

Process or
Condition
Obesity
Obesity
Stress

Finding

↓ Bifidobacterium sp.
↑ Firmicutes:Bacteriodetes
Bifidobacterium infantis
reduces stress
Immunomodulation Lactobacillus, Escherichia
coli promote a Th2 or Treg
differentiation.
α-Synucelopathies Bacterial gavage of human
fecal microbiome into
germ free mice causes
Parkinson’s
pathophysiology in mice
Obesity
Bacteroidetes was less
abundant in obese mice
Obesity
Microbial gavage of lean
mice into obese mice
reduces fat percentage of
obese mice
Diabetes
Non-obese diabetic mice
show a sex bias towards
diabetes incident, which
changes as microbial
gavage is exchanged
between test groups
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Reference
No.
32
33
37
34,35
38

39
40

41

CHAPTER II
THE GUT MICROBIOME: IS FECAL MATTER MICROBIAL
COMPOSITION A PROXY FOR INTESTINAL MICROBIAL
COMPOSITION IN STUDIES OF THE
MICROBIOME?
Enrique Reyes, Dr. Holly Pinkart, Dr. April Binder, Dr. Mary Poulson
Biological Sciences, Central Washington University, Ellensburg, WA

Abstract
Background: As many health phenomena seem to be affected directly and indirectly by the
microbiome, gut microbiome research has increased dramatically in the last decade. Issues like
allergies, cancer, obesity, and other health phenomena have been found to be influenced by the
microbiome. Most of gut microbiome research is done by collecting and sequencing the DNA of
the microbiome of the fecal matter from model organisms or human subjects. Studies that use
this method of sample collection and analysis assume that fecal matter microbiomes are identical
to intestinal microbiomes. At present, no published studies exist which directly compare stool
and intestinal microbial composition.
Results: Bacterial composition was found to be different at all levels of taxonomy between stool
and the regions of the intestines tested. Univariate analysis shows significance between the two
main phyla Firmicutes and Bacteroidetes, as well as main genera like Odoribacter,
Porphyromonas and Alistipes. Relevant species Desulfovibrio desulfuricans and Odoribacter
splanchicus were also found to be significantly different in relative abundance between stool and
some parts of the intestines. α-Diversity was not significantly different between all parts of the
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intestine and stool. β-diversity was found significant between the ileum and stool, with stool
having slightly higher diversity.
Conclusions: Looking at the bacterial composition of both environments and the relative
abundances of the dominant taxa, one can see that that there are key differences between the
intestines and stool. The microbial composition at all levels of taxonomy was found to be
different, therefore, research that targets the gut microbiome should look closely at the specific
taxa being observed. Phyla like Firmicutes and Bacteroidetes were found to have different
abundance within the portions of the intestine and stool, suggesting that phyla level analysis
should be performed by observing each community separately. Interestingly, diversity analysis
was not found significant, suggesting the abundance is different, but the number of different taxa
is similar across the intestinal tract and stool.
Keywords: gut microbiome, microbial community comparison, 16S rDNA amplicon sequencing
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Background
Microbiome research, specifically projects assessing the composition of the gut
microbiome, have become a popular avenue of exploration. From the year 2000 to 2014 a pear
reviewed article internet search for “Gut Microbiome” yielded ~40,000 articles, and when the
word “Ecology” is added to the search it yielded ~13,500 papers. This is a huge increase from
what was observed in the 90’s, where it was reported by Sekirov and colleagues that from 1990
to 1995 no more than 500 articles were published on the gut microbiome (1). It would seem that
microbiome researchers have successfully found a system that affects all other systems of the
body. For example, research suggested that obesity could be explained by the composition of the
gut microbiome, as well as a potential mechanism as to why allergies occur and why they are on
the rise. Connections were also found between the immune system and the gut microbiome, and
many more phenomena were connected to the gut microbiome (2;3;4). Microbial composition
has become an important phenomenon to look at. With the help of the murine (mouse)
microbiome, interesting research was performed showing, for example, the effects of diet and
stress on the microbiome, microbial composition along the intestinal tract, what occurs when the
microbiome is removed at an early age, among others (2;3;4).
Mouse are a commonly used animal model used to study gut microbial composition and
the effects of changes like diet and exercise have on the gut microbiome. The gastro-intestinal
anatomy of the mouse is a similarly complex version of the human intestinal tract, with
structures that are alike, although the composition is slightly different. Cross-sections of organs
show some differences, but the same structures are present in both organisms and they perform
similar functions (7). The human gut microbiome and the mouse gut microbiome are both
dominated by the same phyla: Firmicutes and Bacteroidetes. When looking deeper into the
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species taxonomic level, one can observe differences between the two microbiomes. According
to Ley and colleges 85% of species found in the mouse gut microbiome are not found in the
human microbiome, (5). Even though this dissimilarity is observed there are still roughly 79
genera shared by both humans and mice (6). Both of these findings suggest that composition is
not necessarily dissimilar, but the lower one gets in taxonomy the more diversification these two
organisms have.
Mouse intestinal microbial communities are composed of species belonging to the genera
Lactobacillus, Alistipes, Roseburia, Bifidobacterium, Clostridium, and others. This composition
is similar to that of humans. Relative abundances, on the other hand, are different, as well as
certain communities that are not in humans are found in mice (6; 7). Although, some researchers
have alluded to the issue that these discrepancies and dissimilarities, between human and mouse,
could be better studied if they did not lack comprehensive microbial data due to the inability to
perform research in intestinal matter and fecal matter rather than just fecal matter (8). Even
though mice and humans have dissimilarities, the mouse is still a good model to study
interactions between microbes and the system, changes due to exogenous factors and relative
compositions between portions of the intestine (7).
The inability of these researchers to provide complete conclusions due to the lack of
intestinal data in humans alludes to the question “is fecal matter an adequate proxy for intestinal
microbial composition?”. Many of the conclusions that microbiome researchers have drawn from
studies of the gut microbiome are founded in the assumption that fecal matter is enough to
describe the entirety of the intestinal tract, in terms of microbial composition (Table 1). Research
using mouse models has the ability to extract intestinal matter and study said samples for
microbial composition allowing for a better picture of the microbial communities found in the
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intestines. No one has taken the task to provide a complete comparison of stool matter to
intestinal matter microbial composition by looking at different portions of the intestine and stool
to answer the question is fecal matter can be used to assess adequately the composition of the
intestines. This experiment will allude to this dilemma by looking at the microbial composition
of the intestinal tract in mice as well as stool and performing microbial community comparison
analysis. It is of up most importance to answer this question, since conclusions about the
intestinal tract have been made based off the assumption that fecal matter microbial composition
is an adequate proxy for intestinal microbial composition.
Table 3. Relevant findings from select studies that have used fecal and cecal data.

Microbiome Sample Source
Feces
Feces
Feces
Feces/Intestinal cell
imaging
Feces

Cecum
Cecum
Cecum

Process or
Condition
Obesity
Obesity
Stress

Finding

↓ Bifidobacterium sp.
↑ Firmicutes:Bacteriodetes
Bifidobacterium infantis
reduces stress
Immunomodulation Lactobacillus, Escherichia
coli promote a Th2 or Treg
differentiation.
α-Synucelopathies Gavage of human fecal
microbiome into germ free
mice causes Parkinson’s
pathophysiology in mice
Obesity
Bacteroidetes was less
abundant in obese mice
Obesity
Gavage of lean mice into
obese mice reduces fat
percentage of obese mice
Diabetes
Non-obese diabetic mice
show a sex bias towards
diabetes incident, which
changes as microbial
gavage is exchanged
between test groups
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Reference
No.
2
10
30
3,31
32

33
14
34

Results
Microbial composition: Stool vs. Intestinal Tract
Microbial composition at the phylum level was found to be different in the stool than in
all other sections of the intestine. The Bacteroidetes to Firmicutes ratio was specifically different
in the stool from all intestinal sections, showing an increase in organisms belonging to the
Bacteroidetes phylum and a decrease in organisms belonging to the Firmicutes phylum (Figure
9). The colon showed the most resemblance to the composition of the stool, and the cecum
(Figure 9). This was the case at all levels of taxonomy, although species level community
comparisons were more complex and similar than those for higher taxonomic levels. At the
class level, differences between Bacteroides and Clostridia were observed between stool and all
portions of the intestine tested. Other classes like Bacilli, Deltaproteobacteria, and
Verrucomicrobiae were found to be more abundant in the ileum and colon than in the stool and
cecum. Verrucomicrobiae was also found in small quantity in the cecum, but not as much as in
the colon and ileum (Figure 10).
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Figure 9. Phylum level microbial composition of stool and intestinal tract (ileum, cecum and colon). Each
designation on the X-axis is a mouse sample that corresponded to the specific class assigned.

Figure 10. Class level microbial composition of the stool and the intestinal tract (ileum, cecum and
colon).
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Significant differences among taxa were identified with an ANOVA using MicrobiomeAnalyst software.

At the Phylum level, Firmicutes and Bacteroidetes were found to have significant differences
between portions of the intestine and stool. Bacteroidetes abundance was found to be
significantly different between stool and cecum samples, and stool and ileum samples (Table 2).
Although not statistically significant, there were observable trends of differences between the
ileum and the colon through less abundance of this phylum (Figure 11A). Firmicutes was also
found to have a reversed profile from Bacteroides. Firmicutes was found to be significantly less
abundant in the stool than in the cecum and to the ileum (Table 2). Observable trends also show
that this phylum is not uniformly abundant across the intestinal tract. Although, no statistical
significance was found, the colon also seems to have reduced abundance of Firmicutes compared
to the cecum and the ileum, but it is still more abundant than in the stool. The ileum and cecum
have very similar abundance of this phylum (Figure 11B).
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Figure 11. Relative abundance of statistically different
phyla. (A) Bacteroidetes relative abundance by section of
the intestinal tract ad stool. (B) Firmicutes relative
abundance by section of the intestinal tract and stool. The
asterisks represent outlier.
Table 4. P-values for statistically significant comparisons at the phylum level. all
P-values were calculated using a one-way ANOVA.

Significant
Comparison
Stool-Cecum
Stool-Ileum
Stool-Cecum
Stool-Ileum

Phylum
P-value
Bacteroidetes
0.003
Bacteroidetes >0.001
Firmicutes
0.001
Firmicutes
0.005
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At the class level there were two significant classes that had relevant abundance. The
class Bacteroidea was found to be significantly more abundant in the stool than in the cecum and
in the ileum. Although no significance was found, there is also an observable trend between the
colon and stool as well, where this class is slightly more abundant in the stool than the colon. All
intestinal portions were found to be very similar (Figure 12B). The class Bacilli was also found
to be significantly different between the stool and portions of the intestine. Interestingly, the
ileum was found to be significantly different for Bacilli communities than the colon, cecum and
stool. The ileum was most different from stool, followed by the colon, and the cecum (Table 3).
Differences within the Bacilli class can also be observed between the stool and the colon and
cecum, but no statistical significance was found between these three communities (Figure 12A).
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Figure 12. Relative abundance of statistically significant classes.
(A) Relative abundance of the class Bacilli by section of the
intestinal tract and stool. (B) Relative abundance of the class
Bacteroidea by section of the intestinal tract and stool. Asterisks
represent outliers.
Table 5. P-values for statistically significant comparisons at the Class level.
all P-values were calculated with a one-way ANOVA.

Significant
Comparison

Class
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P-value

Stool-Cecum
Stool-Ileum
Ileum-Colon
Ileum-Cecum
Ileum-Stool

Bacteroidea
Bacteroidea
Bacilli
Bacilli
Bacilli

0.003
>0.001
0.018
0.002
0.001

At the order level two taxa were found to be significant from all others. The order
Bacteroidales was found to be significantly more abundant in the stool. Significance was found
between stool and ileum samples and between stool and cecum samples (Table 3). Colon
samples were not significantly different than those from the stool, but a trend can be observed,
where Bacteroidales was found to be more abundance in stool than in the colon samples (Figure
13A). The order Lactobacillales was found to be significantly less abundant in samples from the
stool as compared to the ileum, as well. Lactobacillales was also found to be significantly more
abundant in the ileum than in the cecum and colon (Table 4). Trends in differences between the
stool and the colon samples were also observed, but none were significantly different. The range
of abundances for Lactobacillales samples was found to be very broad between the samples,
especially for samples taken from the ileum portion of the intestine (Figure 13B).

32

A

8000000
7000000

Abundance

6000000
5000000
4000000
3000000
2000000
1000000
0

B

aIleum

Cecum

Colon

Stool

aIleum

Cecum

Colon

Stool

7000000
6000000

Abundance

5000000
4000000
3000000
2000000
1000000
0

Figure 13. Relative abundance of statistically significant
orders. (A) Relative abundance for the order Bacteroidiales by
section of the intestinal tract and stool. (B) Relative
abundance of the order Lactobacillales by section of intestinal
tract and stool. Asterisks represent outliers. Asterisks
represent outliers
Table 6. P-values for statistically significant comparisons at the Order level.
all P-values were calculated with a one-way ANOVA.

Significant
Comparison
Stool-Ileum
Stool-Cecum

Order
Bacteroidales
Bacteroidales
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P-value
<0.001
0.003

Stool-Ileum
Ileum-Cecum
Ileum-Colon

Lactobacillales
Lactobacillales
Lactobacillales

0.001
0.003
0.019

At the family level two features were found to be significantly different from the rest.
The family Rikenellaceae was found to be significantly more abundant in stool samples than in
all other intestinal portions. The largest difference was observed between stool and ileum
samples, followed by stool and cecum samples, and stool and colon samples (Table 5). There
were also two observable trends that showed cecum samples being different than the ileum and a
large range of differences among samples taken from the colon (Figure 14). The family
Porphyromonadaceae was found to be significantly different between the stool and two portions
of the intestine. This family was found to be significantly more abundant in samples from the
stool than from the cecum, or from the ileum (Table 5). Observable trends show that
Porphyromonadaceae was also more abundant in the stool than in the colon, although no
statistical significance was found between these two sample types (Figure 14).
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Figure 14. Relative abundance of statistically significant
families. (A) Porphyromonadaceae relative abundance across
the intestinal tract a stool. (B) Rikenellaceae relative
abundance across the intestinal tract and stool. Asterisks
represent outliers. Asterisks represent outliers.
Table 7. P-values for statistically significant comparisons at the Family level.
all P-values were calculated with a one-way ANOVA.

Significant
Comparison
Stool-Cecum
Stool-Ileum
Stool-Ileum
Stool-Cecum
Stool-Colon

PFamily
value
Porphyromonadaceae
0.006
Porphyromonadaceae
0.003
Rikenellaceae
>0.001
Rikenellaceae
0.001
Rikenellaceae
0.001
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Three genera were found to differ significantly in types and relevant abundance across
the intestinal tract. The genus Alistipes was found to be more abundant in the stool samples than
in all other intestinal portions tested. The largest difference was found between samples from the
stool and the ileum, followed by the cecum and the stool, and the stool and the cecum (Table 6).
Interestingly, samples from the cecum and the ileum seem to be very different, although there
was no statistical significance found between these two sample types. Samples from the colon
showed a high range of data points (Figure 15). The genus Odoribacter was also found to differ
significantly between samples from the intestine and stool. Bacteria belonging to the genus
Odoribacter were found to be significantly more abundant in stool samples than in all three
portions of the intestine tested. The largest difference was found between samples from the stool
and the ileum, followed by the colon, and the cecum (Table 6). All portions of the intestine seem
to be very similar although cecum samples showed some difference when compared to the ileum,
no statistical significance was found (Figure 15). Lastly, the genus Porphyromonas was found to
have significantly different abundances between samples from the stool and from portions of the
intestine. Stool samples were found to have higher abundance of Porphyromonas than samples
from the cecum and the ileum (Table 6). There is also a trend that can be observed between colon
and ileum samples showing that the colon has higher abundance of Porphyromonas species than
the ileum, although no statistical significance was found. There was a high variability data points
among the colon samples differences between samples (Figure 15). Species level univariate
analysis showed many significant features, but they were omitted due to most of them having
extremely low abundance.
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Figure 15. Relative abundance for statistically significant genera. (A) Porphyromonas relative abundance
across the intestinal tract and stool. (B) Odoribacter relative abundance across the intestinal tract and stool. (C)
Alistipes relative abundance across the intestinal tract and stool. Asterisks represent outliers.
Table 8. P-values for statistically significant comparisons at the Genus level.
all P-values were calculated with a one-way ANOVA in MiniTab.

Significant
Comparison
Stool-Ileum
Stool-Cecum
Stool-Colon
Stool-Ileum
Stool-Cecum
Stool-Colon
Stool-Ileum
Stool-Cecum

Genus
Alistipes
Alistipes
Alistipes
Odoribacter
Odoribacter
Odoribacter
Porphyromonas
Porphyromonas
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P-value
<0.001
<0.001
<0.001
<0.001
<0.001
0.003
0.008
0.001

At the species level there were two species that were relevantly abundant and
significantly different between samples from the intestine and the stool. The species Bacteroides
acidifaciens was found to be slightly more abundant in samples from the stool than from the
ileum. Although only this comparison was found to be significant, observable trends show more
abundance in stool than the cecum (Table 7; Figure 16). The organism was similarly abundant
between portions of the intestine. Also, a high amount of variation was found among stool
samples (Figure 16). The species Dorea massiliensis was more abundant in samples from the
stool than in all portions of the intestine. This organism was more abundant in samples from the
stool than from the ileum the most, followed by the colon and cecum. All portions of the
intestine where similar (Table 7). The range of the colon samples was very high suggesting large
differences in D. massiliensis abundance from individual to individual. Although, only the stool
was significantly different from the intestine, observable trends suggest that there might be a
difference between colon and ileum, but due to the large variability within colon samples,
significance was not found between these two sample types (Figure 16).
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Figure 16. Relative abundance for statistically
significant species. (A) Bacteroides acidifaciens
percentage abundance across the intestinal tract and
stool. (B) Dorea massiliensis percentage abundance
across the intestinal tract and stool. Asterisks represent
outliers.
Table 7. P-values for statistically significant comparisons at the Species level.
all P-values were calculated with a one-way ANOVA.

Significant
Comparison
Stool-Cecum
Stool-Ileum
Stool-Colon
Stool-Ileum

Species
Dorea massiliensis
Dorea massiliensis
Dorea massiliensis
Bacteroides
acidifaciens

39

P-value
0.001
<0.001
<0.001
0.004

Diversity Analysis
Alpha-diversity was assessed by Shannon’s Diversity Index and β-Diversity was assessed by
Bay-Curtis dissimilarity test. At the genus level of taxonomy there were no significant difference
between the intestine and the stool when looking at α-diversity (Figure 17). The Bay-Curtis
analysis for β-diversity showed significance within the comparisons between the stool and
intestine. Stool was found to be more diverse than the ileum (P-value: 0.003). Observable trends
show individual clustering between the parts of the intestine and stool, suggesting that there is a
difference between all portions of the intestine and stool (Figure 18).

Figure 17. Shannon's diversity index of each intestinal portion and stool. No significance was observed
between any of the groups.
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Figure 18. β-diversity analysis. PCOA showing Bay-Curtis Dissimilarity test data. Statistical significance
was only found between the Ileum and Stool, but clustering is observed with all sources (P-value: 0.003).

Discussion

Bacterial composition and diversity were compared between fecal samples and intestinal

samples in mice. Mouse bacterial composition is similar to human bacterial composition,
although abundance seem to be different. For example, mice and humans share some genera
including Alistipes, Odoribacter and Turicobacter but some are in lower abundance in mice than
in humans (6). Even so, mice are a good model for intestinal microbial community comparison
because the intestinal tract is similar in composition, although the researchers admit that the
strength of these findings is lowered due to only observing fecal matter. (7;8).
The intestinal microbial composition of humans and mice a like, has been explored
thoroughly, while fecal matter has been used extensively to draw conclusions about the many
phenomena that the gut microbiome is connected to, no one has taken on the task of comparing
both communities and the communities across the intestinal tract. By comparing the bacterial
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composition of the intestinal tract and stool of mice as well as the diversity of the microbiome
across the mouse intestinal tract we can shed some light into the adequacy of the assumption that
fecal matter bacterial composition is a proper proxy for intestinal microbial composition.
At the phylum level of taxonomy, bacterial composition was found to be different between stool
and all portions of the intestine. The phylum Firmicutes was found to be significantly more
abundant in stool and the ileum (Figure 15). This profile, then, is very similar to that of the
cecum and colon where the Firmicutes to Bacteroidetes ratio is highly dominated by
Bacteroidetes. This finding suggests that as the intestinal tract proceeds from proximal to distal
end, there is a change in microbial composition observed at the phylum level. Previous studies in
the composition of the intestinal tract have found similar observations, by concluding that
diversity and complexity of the intestinal tract increases from proximal to distal end (4). This
does not only occur at the phylum level, but at all lower levels of taxonomy. The phyla
Firmicutes and Bacteroidetes have are highly studied taxa, and have been correlated to obesity.
The Firmicutes to Bacteroidetes ratio has been previously used to determine an obese
composition. In a study aimed to assess the energy harvest capacity of an obese microbiome,
researchers used fecal samples to assess the composition of the intestinal tract and how it is
correlated to obesity. They found higher Firmicutes than Bacteroidetes is a characteristic of an
obese phenotype (11). Our findings suggest that Bacteroidetes is often lower than Firmicutes in
stool (Figure 11B). At the class level of taxonomy, the microbiome for the ileum was very
different, not only from the stool, but also from all portions of the intestine sampled. Classes
such as Clostridia and Bacteroidea are very similar across the intestinal tract, but are found to be
in different proportions in the stool; the class Clostridia is found in low numbers in stool samples
whereas Bacteroidea is highly abundant. This is very distinct from all other portions of the
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intestines. Other classes are also more abundant in certain portions of the intestinal tract than in
the stool, for example the class Bacilli was found to be highly abundant in the ileum, but not in
the stool, suggesting that along the intestinal tract, the organisms belonging to this class are not
reaching stool. Some of these findings are in agreement with previous research. Sheghuan and
colleagues (9) found the class Bacilli to be highly abundant in the ileum, but less abundant in
other portions of the intestinal tract. This class is a target of study for the effects of diet in the gut
microbiome. A study assessing the effects of diets on the humanized mice microbiome found that
the class bacilli is highly abundant in Western diets, but less abundant in other diets, suggesting
that western countries have different microbiomes due to the diet that is often consumed (12).
This experiment only used fecal matter to draw conclusions about the intestinal tract
composition. Our findings suggest that the mouse microbiome has low bacilli in stool. The class
Bacteroidea, was found to have a similar abundance across the intestinal tract, although they
found it to be high in the Ileum, which is in opposition to our findings (9). This difference might
be due to strain and diet differences between the studies.
The genera Odoribacter, Porphyromonas and Alistipes were found to be more abundant
in the stool than in all portions of the intestine. Organisms belonging to the Alistipes are very
relevant, and have opened an avenue of research concerning the gut-brain axis (27). Previous
research, which used only fecal matter for samples, found that this genus is decreased in mice
that experience severe stress and when gavaged into germ-free mice yielded a stress phenotype
(27). Interestingly it was found high in stool in our study, which might suggest that the depletion
of this organism during stress events might occur in the colon, which was found to be similar
form stool across all taxa. The genus Odoribacter is a known commensal organism in the human
and murine gut. Recent studies have found that this organism is highly present in neonatal stages
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(14). It was not specified which portion of the intestine this organism was most prevalent in or if
it is transient or if it colonizes the intestine since they only used fecal matter at one point in time
(14). Our study suggests that it is not highly abundant in the intestinal tract, but highly abundant
in stool, which might suggest why the previously mentioned project observed it to be in such
high abundance. Another relevant genus that was found to differ in abundance between stool and
the intestinal tract is the Porphyromona genus, although most of the research around this genus
has been focused in a specific organism, Porphyromonas gingivalis, which has been foud to have
an effect in Alzheimer patients. Periodontal pathogen antibodies have been found in significantly
high amounts in Alzheimer patients. The researchers suggest that organisms like Porphyromonas
gingivalis are connect pathophysiology of the disease (28).
At the species level, organisms known to be important to health, in terms of immune
responses, were found to be different. The organism Bacteroides acidifaciens was found to be
significantly more prevalent in stool. This organism is known for reducing inflammation,
improving glucose sensitivity and reducing obesity in mice. These conclusions were drawn from
mouse ceca, but also only from human feces suggesting that the results might be skewed due to
inaccuracy (10). Dorea massiliensis was found to be more abundant in stool than in any other
portion of the intestine. This organism has not been highly studied, since it was a candidate
organism, or an organism that is in the process of being assigned to that certain taxonomic
assignation, until recently (29). Researchers that assigned this taxonomic name found this
organism in a single stool sample from an Anorexia nervosa patient (29).
When looking at diversity, specifically the Shannon’s index, there was no significance
found. These findings contradict previous research that puts the diversity in the ileum being
lower than other portions of the intestine, in mice (9). The Bay-Curtis dissimilarity test, on the
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other hand, showed significance between the stool and ileum. The stool was more diverse and it
clustered together apart from the ileum, which clustered together as well (Figure 18). Sheguan
and colleagues found similar results, where local diversity was found to be significantly different
between the intestinal tract (9). Our findings suggest that just stool is differently diverse, but due
to different methodology and diet, conclusions might be different.
There is convincing evidence showing that the microbial composition of the stool and the
intestinal tract is different. These findings suggest that fecal matter is not an adequate proxy for
intestinal microbial composition. Within the intestine there is also variability in the microbiome.
Therefore, individual portions of the intestine should be looked at separately when making
conclusions about the microbial composition and abundance of the gut. Similar to our findings,
Shenghuan and colleagues also found that each portion of the intestines has its own community,
showing multiple differences between the jejunum, ileum, cecum and colon (9). Our findings
suggest that microbial composition along the intestinal tract changes, as reported by others (9),
and now we add that fecal matter also has different microbial composition from regions of the
intestine. Further research needs to be performed on this matter. Research alluding to viability of
microbial cells, would answer this question with a more encompassing conclusion. In this
experiment we lacked the ability to differentiate between viable and non-viable cells. Most
microbes in our gut and mouse gut are obligate anaerobes, therefore it is important to look at
viability in stool, specifically. These organisms would have died as soon as contact with oxygen
was had and they would not be considered part of the fecal microbiome at said point in time.
Although, viability is an issue that needs to be researched more, our findings still suggest that
there are differences between the microbial composition of the intestinal tract and stool. Stool
bacterial composition and diversity can be a good source of information for studies of the
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microbiome, but should not be considered an adequate proxy for intestinal bacterial composition
and diversity.

Methods
Tissue and stool collection
Eight approximately six-week-old wild-type C57BL/6 male mice were used in this study.
All mice were housed and maintained under Protocol #A101604, which was approved by the
Central Washington University Institutional Animal Care and Use Committee. All mice had
access to food ad libitum and were fed Mazuri Rodent Breeder 6F diet. This diet is composed of
16% crude protein, 6% crude fat, 7% crude fiber, 12% moisture and ~8% mixture of various
minerals. Stool samples were collected 30 seconds before euthanasia by placing the mice on a
disinfected tray and allowing the mice to produce stool pellets, which were collected aseptically
and stored at -80°C until DNA extraction. Following stool collection, mice were euthanized by
rendering CO2 followed by cervical dislocation. Following euthanasia and using aseptic
technique, the intestinal tract was removed from each mouse. The intestinal tract was aseptically
divided into ileum, cecum and colon, then stored at -80°C until DNA extraction.

DNA extraction and 16S rDNA amplicon sequencing
Intestinal samples were sub-sectioned into three 25mg-35mg tissue sections. DNA from
all intestinal samples was extracted using the DNeasy kit (Qiagen, Inc., Germantown, MD) for
tissue and blood. DNA was then quantified using absorbance at 260 nm on a Beckman DU 640B
UV spectrometer, and quality was assessed using the 260/280 nm ratio. The extracted DNA were
then stored at -80ºC. DNA from stool samples was extracted using the QIA AMP Stool DNA
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extraction kit (Qiagen, Inc., Germantown, MD). DNA for these samples was also quantified and
checked for quality via UV absorbance using the same parameters, and stored at -80ºC. All DNA
samples were sent to Mr. DNA Laboratory (Shallowater, TX) for 16S rDNA amplicon
sequencing and taxonomic assignment. The 16S rRNA V4 variable region PCR primers 515/806
were selected for use in a one-step 30 cycle PCR. The HotStarTaq Plus Master Mix Kit (Qiagen,
USA). The following conditions were used for PCR: 94°C (3 minutes), followed by 30 cycles of
94°C (30 seconds), 53°C (40 seconds) and 72°C (1 minute), after which a final elongation step at
72°C (5 minutes). Sequencing was performed on an Ion Torrent PGM using manufacturer’s
protocol. Sequence data was processed with proprietary analysis pipeline (MR DNA,
Shallowater, TX, USA).

Microbial Community Comparison and Statistical Analysis
Microbial community comparison was assessed using the MicrobiomeAnalyst Web-based
software. The Marker Data Profiling (MDP) module was used, which takes 16S rDNA data and
yields relative abundance, univariate analysis, α−diversity, β-diversity and significance through
statistical tests like Analysis of Variance and Mann-Whitney test. The data set was not
normalized, but was subjected to total sum scaling. This allows for more robust statistical
analysis. All OTU counts less than 4 and all sequences data representing less than 10% of the
whole data set were removed as a filtering method to minimize possible sequencing errors and
DNA contaminants. Performing this data filtering removed a total of 408 features from the data
set.
Alpha diversity was assessed by Shannon’s Diversity Index, and significance was
assessed using an ANOVA with a Tukey post-hoc test. Beta Diversity was assessed by BayCurtis dissimilarity test, and significance was assessed using a one-way ANOVA followed by a
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post hoc Tukey test. All statistical tests were performed by MirobiomeAnalyst or in MiniTab
(Ryan et al., University of Pennsylvania, 1972). All statistical tests were performed with a 0.05
P-value parameter in MiniTab.
Univariate analysis was performed using MicrobiomeAnalyst at all levels of taxonomy.
Individual significant features that had relevant abundance within the data set were separated and
assessed for significance individually. Significance was assessed by a one-way ANOVA followed
by a post hoc Tukey test to assess the source of the difference or similarity. All statistical tests
were performed with a 0.05 P-value parameter in MiniTab.
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